Health
US Study finds why some COVID-19 patients may not develop lasting immunity – EdexLive
This process, along with controlled mutations in antibody genes, allows the immune system to select for and immortalise B cells that make the best antibodies against a particular pathogen
A US study led by an Indian-origin researcher has found that high levels of some cytokines seen in Covid-19 patients, as part of a cytokine storm, may prevent the development of long-term immunity to coronavirus.
“By using our understanding of how two different types of immune cells normally collaborate to make the best antibodies, we were able to find a mechanism that could explain this lower-quality immune response in Covid-19 patients,” said Shiv Pillai from the Massachusetts General Hospita…
-
General11 hours agoAussie travellers devastated after US government shutdown forces tourist attractions to close
-
Business11 hours agoWhat’s Macquarie’s price target on ANZ shares ahead of its 13 October strategy day?
-
General13 hours agoOverheated share markets may risk financial meltdown
-
Business15 hours agoWhere will the CBA share price go next? Here’s what the experts say